Streetbeat News

Partnerships

ORGS

Orgenesis Inc. (NASDAQ:ORGS) is expanding its cell and gene therapy development and patient access across the US through its subsidiary Octomera, in partnership with CGT Global. The collaboration aims to leverage CGT Global's network of CGT Clinics and healthcare partnerships to commercialize CGTs in California and other US locations. The companies plan to align resources to place Octomera Mobile Processing Units & Labs (OMPULs) for leukapheresis and the production of CAR-T and TILS products. The partnership is expected to grow as CGT Global currently partners with 32 hospitals and anticipates partnering with over 200 hospitals by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:20 pm

KAVL

PM

Kaival Brands has received its initial royalty payment from Philip Morris International due to increased international sales. This follows a recently amended agreement between the two companies.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:17 pm

BLNK

Blink Charging has partnered with Moberly Motor Company and Electric Era to bring fast and efficient DC charging to the dealership. This collaboration aims to provide a seamless charging experience for electric vehicle owners.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:16 pm

AVGO

Broadcom's shares are trading lower following a report by The Information suggesting that Google is considering dropping Broadcom as its AI chip supplier.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:13 pm

DARE

Daré Bioscience, Inc. (NASDAQ:DARE) will receive a payment of approximately $4.5 million as the latest installment under a grant agreement to advance the development of its investigational contraceptive DARE-LARC1. The total grant could reach up to $49 million. Daré received an initial $11.5 million payment in 2021 and aggregate payments of approximately $12.4 million in 2022. The company is also advancing the late-stage development of Ovaprene, a hormone-free monthly intravaginal contraceptive. Daré has a license agreement with Bayer for the development and commercialization of Ovaprene in the United States, if approved by the FDA.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:06 pm

HSCS

HeartSciences has signed definitive agreements with the Icahn School of Medicine at Mount Sinai to commercialize artificial intelligence cardiovascular algorithms. The deal could potentially boost HeartSciences' product portfolio and market presence.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:04 pm

BNGO

Bionano Genomics' (NASDAQ:BNGO) OEM partner Ecobono has received approval from China's National Medical Products Administration (NMPA) for Bionano's DNA isolation kits for optical genome mapping (OGM). This allows Ecobono to sell OGM reagents to independent clinical laboratories and Chinese hospitals. This is the third such approval for a Bionano OEM partner in China.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:04 pm

VEDU

Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) has announced plans to diversify its business into three sectors: Education, Life Sciences, and Artificial Intelligence. The company has also appointed Mr. Charlie Penn as Chief Operating Officer, effective from September 14, 2023. Mr. Penn has extensive experience in investment and education management.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 12:03 pm

UBER

White Castle has partnered with Uber Direct to offer delivery services through its own app. The service will be available in all of White Castle's restaurant markets, allowing customers to pay the same price for their meal as if they were visiting the restaurant, with a flat delivery fee of $4.99. The partnership with Uber Direct makes the app the best value for White Castle delivery.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 11:48 am

RIG

Nauticus Robotics has secured a term loan agreement with existing stakeholders Transocean, ATW Partners, Material Impact, and RCB Equities. The agreement provides up to $20M in secured term loans.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 11:37 am